ScoreWhy is Sudeep Pharma Ltd ?
1
High Management Efficiency with a high ROE of 0%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.68 times
3
Poor long term growth as Operating profit has grown by an annual rate 0% of over the last 5 years
4
Positive results in Mar 26
- NET SALES(Q) Highest at Rs 182.34 cr
- PBDIT(Q) Highest at Rs 62.59 cr.
- PBT LESS OI(Q) Highest at Rs 56.27 cr.
5
With ROE of 19.6, it has a Very Expensive valuation with a 9.8 Price to Book Value
- Over the past year, while the stock has generated a return of NA, its profits have risen by 25%
6
Majority shareholders : Promoters
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Sudeep Pharma should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
No Data Found
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
33.98
Debt to EBITDA (avg)
0.72
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.65
Tax Ratio
23.58%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
19.67%
ROCE (avg)
24.88%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
50
Industry P/E
33
Price to Book Value
9.80
EV to EBIT
41.95
EV to EBITDA
39.15
EV to Capital Employed
9.45
EV to Sales
13.53
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
22.53%
ROE (Latest)
19.57%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
RSI
No Signal
Bollinger Bands
Bullish
KST
Dow Theory
Bullish
Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend10What is working for the Company
NET SALES(Q)
Highest at Rs 182.34 cr
PBDIT(Q)
Highest at Rs 62.59 cr.
PBT LESS OI(Q)
Highest at Rs 56.27 cr.
PAT(Q)
Highest at Rs 48.88 cr.
-3What is not working for the Company
INTEREST(Q)
Highest at Rs 2.44 cr
Loading Valuation Snapshot...
Here's what is working for Sudeep Pharma
Net Sales - Quarterly
Highest at Rs 182.34 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 62.59 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 56.27 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 48.88 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Here's what is not working for Sudeep Pharma
Interest - Quarterly
At Rs 2.44 cr has Grown at 108.55%
Quarter on Quarter (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Interest - Quarterly
Highest at Rs 2.44 cr
in the last five quarters and Increased by 108.55 % (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
